Total Medical devices industry cross border M&A deals worth $2.7bn were announced globally in Q2 2022, led by ResMed’s $1bn acquisition of MediFox DAN Group, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 102.3% over the previous quarter of $1.33bn and a drop of 47.2% when compared with the last four-quarter average, which stood at $5.09bn.

Comparing cross border M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $2.16bn. At the country level, the Germany topped the list in terms of deal value at $1.78bn.

In terms of volumes, Europe emerged as the top region for Medical devices industry cross border M&A deals globally, followed by North America and then Asia-Pacific.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The top country in terms of cross border M&A deals activity in Q2 2022 was the US with 11 deals, followed by Germany with nine and the UK with five.

In 2022, at the end of , cross border M&A deals worth $4.03bn were announced globally in Medical devices industry, marking a decrease of 54.5% year on year.

Cross Border M&A deals in Medical devices industry in Q2 2022: Top deals

The top five cross border M&A deals in Medical devices industry accounted for 54.5% of the overall value during Q2 2022.

The combined value of the top deals stood at $2.09bn, against the overall value of $2.7bn recorded for the quarter.

The top five Medical devices industry cross border Medical devices deals of Q2 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $541.63m acquisition of Phenox by Wallaby Medical

3) Boston Scientific $230m acquisition deal for 64% stake in M.I.Tech

4) The $177.8m acquisition of Guardant Health AMEA by Guardant Health

5) Integer $141.73m acquisition deal with Aran Biomedical